KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Revenue: 2009-2024

Historic Revenue for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Dec 2024 value amounting to $179.3 million.

  • Rigel Pharmaceuticals' Revenue rose 25.59% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $282.1 million, marking a year-over-year increase of 79.13%. This contributed to the annual value of $179.3 million for FY2024, which is 53.38% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Revenue of $179.3 million as of FY2024, which was up 53.38% from $116.9 million recorded in FY2023.
  • Rigel Pharmaceuticals' 5-year Revenue high stood at $179.3 million for FY2024, and its period low was $108.6 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $120.2 million (2022), whereas its average is $138.8 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Revenue skyrocketed by 83.21% in 2020 and then declined by 19.43% in 2022.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Revenue stood at $108.6 million in 2020, then skyrocketed by 37.39% to $149.2 million in 2021, then declined by 19.43% to $120.2 million in 2022, then declined by 2.79% to $116.9 million in 2023, then spiked by 53.38% to $179.3 million in 2024.